2,6,10-Dodecatrienoicacid, 3,7,11-trimethyl-, methyl ester (10485-70-8)

Identification
Name:	2,6,10-Dodecatrienoicacid, 3,7,11-trimethyl-, methyl ester
Synonyms:	Farnesenicacid, methyl ester (6CI); Farnesyl methyl ester; Methyl3,7,11-trimethyl-2,6,10-dodecatrienoate; Methyl farnesate; Methyl farnesoate;Methyl farnesylate
CAS:	10485-70-8
Molecular Formula:	C16H26 O2
Molecular Weight:	250.38
InChI:	InChI=1/C16H26O2/c1-13(2)8-6-9-14(3)10-7-11-15(4)12-16(17)18-5/h8,10,12H,6-7,9,11H2,1-5H3/b14-10+,15-12+
Molecular Structure:
Properties
Flash Point:	161.7°C
Boiling Point:	336°Cat760mmHg
Density:	0.905g/cm³
Refractive index:	1.473
Flash Point:	161.7°C
Safety Data

Other Product

2,6,10-Dodecatrienoicacid,12-(acetyloxy)-6-[(acetyloxy)methyl]-10-methyl-2-(4-methyl-3-methylenepentyl)-,(2Z,6Z,10Z)-
2,6,10-Dodecatrienoicacid, 3,7,11-trimethyl-
Spiro[2-cyclohexene-1,2'(1'H)-cyclopenta[de]naphthacene]-9'-carboxamide,7',7'a,8',11',11'a,12'-hexahydro-5',6',7'a,10',11'a,12'-hexahydroxy-3'-methoxy-2,6,6-trimethyl-7',8'-dioxo-,(1R,7'aR,11'aR,12'R)-rel-(-)-
2,6,10-Dodecatrienoicacid,12-(acetyloxy)-6-[(acetyloxy)methyl]-10-methyl-2-(4-methyl-3-methylenepentyl)-,(3aS,4S,5S,6E,10E,11aR)-6-formyl-2,3,3a,4,5,8,9,11a-octahydro-4-[[2-(hydroxymethyl)-1-oxo-2-propen-1-yl]oxy]-10-methyl-3-methylene-2-oxocyclodeca[b]furan-5-ylester, (2Z,6Z,10Z)-
2,7,9-Undecatrienoicacid,5-(acetyloxy)-11-[[10-(acetyloxy)-7-hydroxy-5,9-dimethyl-1-[(1E)-1-methyl-3-oxo-1-butenyl]-6-oxo-6H-naphtho[2,1-d][1,3]dioxin-8-yl]amino]-4,6,10-trimethyl-2-[(1E)-2-methyl-3-oxo-1-propenyl]-11-oxo-,methyl ester, (2E,4R,5S,6S,7Z,9E)- (9CI)
Benzoic acid,2,4-dihydroxy-6-methyl-,(1'R,2'aR,4'R,4'aR,7R,7'S,9'aR,9'bR,11'aR)-3-[(1E)-2-carboxyethenyl]-1',2',2'a,3',4'a,6',7,7',8,8',9',9'a,9'b,10',11',11'a-hexadecahydro-7'-hydroxy-7,9'a,11'a-trimethyl-6,8-dioxo-1'-[(1R,2E,4R)-1,4,5-trimethyl-2-hexenyl]spiro[1H-2-benzopyran-5(6H),4'-[4H]indeno[6,7,1-mna]anthracen]-7-ylester (9CI)
1/C12H9NO/c14-9-11-3-1-2-4-12(11)10-5-7-13-8-6-10/h1-9
2,6,10-Dodecatrienoicacid,12-(2,5-dihydroxy-3-methylphenyl)-6,10-dimethyl-2-(4-methyl-3-penten-1-yl)-,(2Z,6E,10E)-
2H-Indeno[5',6':4,5]furo[2,3-d]oxepin-1-aceticacid,10-(acetyloxy)-2-[(acetyloxy)methyl]-8-(3-furanyl)tetradecahydro-10a-hydroxy-2,7a,11b-trimethyl-11-methylene-7-(3-methyl-1-oxobutoxy)-4-oxo-,methyl ester, (1R,2S,5aS,6aR,7R,7aR,8S,10S,10aS,11aR,11bR)-
1/C8H5BrCl2/c9-7-3-1-6(2-4-7)5-8(10)11/h1-5
1/C11H7ClO2/c12-9-3-1-2-8(6-9)11-5-4-10(7-13)14-11/h1-7
Spiro[2-cyclohexene-1,2'(1'H)-cyclopenta[de]naphthacene]-9'-carboxamide,6'-(b-D-glucopyranosyloxy)-7',7'a,8',11',11'a,12'-hexahydro-5',7'a,10',11'a,12'-pentahydroxy-3'-methoxy-2,6,6-trimethyl-7',8'-dioxo-,[2'S-(2'a,7'ab,11'ab,12'b)]- (9CI)
1/C9H7NO2/c1-10-7-5-3-2-4-6(7)8(11)9(10)12/h2-5H,1H
10-Dodecenoic acid, 11-methyl-7-oxo-, ethyl ester
1/C7H10N4O/c1-2-9-10-7(8-1)11-3-5-12-6-4-11/h1-2H,3-6H
1/C7H3Cl3O/c8-5-1-2-6(9)7(10)4(5)3-11/h1-3
1/C6H6O3S2/c1-2-9-5(7)4-3-10-11-6(4)8/h3H,2H2,1H
1/C12H19N/c1-8(2)10-6-5-7-11(9(3)4)12(10)13/h5-9H,13H2,1-4H
1/C9H15NO/c1-2-4-9(3-1)10-5-7-11-8-6-10/h3H,1-2,4-8H
1/C10H17NO/c12-10-7-4-8-11(10)9-5-2-1-3-6-9/h9H,1-8H